#Latest news with #Replimune Group IncBloomberg7 days agoHealthBloombergFDA Rejects Replimune's Skin Cancer Treatment, Shares SinkUS regulators rejected a skin cancer treatment from Replimune Group Inc. in another sign of the agency's new leadership taking a hard line on drug approvals. The US Food and Drug Administration denied the company's application to treat advanced melanoma with a combination of its immunotherapy and another cancer drug.
Bloomberg7 days agoHealthBloombergFDA Rejects Replimune's Skin Cancer Treatment, Shares SinkUS regulators rejected a skin cancer treatment from Replimune Group Inc. in another sign of the agency's new leadership taking a hard line on drug approvals. The US Food and Drug Administration denied the company's application to treat advanced melanoma with a combination of its immunotherapy and another cancer drug.
7 days ago
